Diffusion Pharmaceuticals, Inc. reported raising $15.8M in a private placement filing on March 16, 2017
Mar 18, 2017 - RelSci Data Update
Investments

Background Information:
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages in the provision of oncology-focused biotechnology. It involves in research and development, and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.
In The News:
Mark T. Giles is now serving in a new board position at Diffusion Pharmaceuticals, Inc.
July 3, 2018  •  RelSci
Stratus Pharmaceuticals Announces Results Of FDA Inspection To Stratus's Distribution Center
June 20, 2018  •  PR Newswire
-Diffusion Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update
May 17, 2018  •  ENP Newswire
Diffusion Pharmaceuticals, Inc. is a clinical stage company which engages in the provision of oncology-focused biotechnology. It involves in research and development, and manufacture of drug products for the treatment of cancer in combination with radiation and chemotherapy. The company was founded by David G. Kalergis and John L. Gainer in 2001 and is headquartered in Charlottesville, VA.